Population Pharmacokinetics of Cycloserine and Pharmacokinetic/Pharmacodynamic Target Attainment in Multidrug-Resistant Tuberculosis Patients Dosed with Terizidone

Cycloserine is a WHO group B drug for the treatment of multidrug-resistant tuberculosis (TB). Pharmacokinetic/pharmacodynamic data for cycloserine when dosed as terizidone are sparse. The aim of this analysis was to describe the population pharmacokinetics of cycloserine when administered as terizid...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Antimicrob Agents Chemother
Hlavní autoři: Chirehwa, Maxwell T., Court, Richard, de Kock, Mariana, Wiesner, Lubbe, de Vries, Nihal, Harding, Joseph, Gumbo, Tawanda, Maartens, Gary, Warren, Rob, Denti, Paolo, McIlleron, Helen
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Microbiology 2020
Témata:
Pharmacology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7577169/
https://ncbi.nlm.nih.gov/pubmed/32816738
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.01381-20
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky